Biotech Values

[flatlander_60048]

Yes, but Januvia got my goat to a greater extent since at one point NVS was ahead of Merk. Now the market will become fragmented with me too drugs. As you pointed out more than 60 countries have decided that the testing that was requested by FDA was unnecessary for their approval. The market consolidation which we are seeing will need to run for a while before the redundancy in the research programs gets washed out.

FL